CenterWatch

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Mobile Alabama 36608

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

California

UCLA
Los Angeles California 90025

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Elite Clinical Trials, Inc.
Wildomar California 92595

Does Your Child Suffer from Allergies or Hives?

View More ▼

Fresno California 93720

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Riverside California 92506

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

San Jose California 95117

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Colorado

National Jewish Health
Denver Colorado 80206

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Illinois

ChicagoENT
Chicago Illinois 60657

A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

University of Chicago
Chicago Illinois 60637

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Northwestern University
Chicago Illinois 60611

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

University of Chicago
Chicago Illinois 60637

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Kentucky

Bowling Green Kentucky 42101

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Maryland

UPDATED

PAREXEL
Baltimore Maryland 21225

Seasonal Allergy Eczema

Johns Hopkins
Baltimore Maryland 21224

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Johns Hopkins
Baltimore Maryland 21224

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

View More ▼

Columbia Maryland 21044

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Waldorf Maryland 20602

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Massachusetts

Minnesota

View More ▼

Minneapolis Minnesota 55402

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Missouri

The Clinical Research Center, LLC
St. Louis Missouri 63141

Do You Suffer from Dust Mite Allergies? If so You May Quailfy for a House Dust Mite Study.

Nebraska

Papillion Nebraska 68046

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

New York

The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
Bronx New York 10461

Diagnosis of Aspirin Hypersensitivity by Measuring Arachidonic Acid Metabolites after Low Dose Aspirin Challenge

Winthrop University Hospital Clinical Trials Center
Mineola New York 11501

Children and Adolescents with Hereditary Angioedema (HAE)

Winthrop University Hospital Clinical Trials Center
Mineola New York 11501

Study for adults with Hereditary Angioedema (HAE)

The Rockefeller University Hospital
New York New York 10065

Food Allergy, Phenotype, Regulation and Development of the Immune System in Adult Atopic Dermatitis Patients

View More ▼

Brooklyn New York 11229

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

North Carolina

UNC Chapel Hill
Chapel Hill North Carolina 27599

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Ohio

Cincinnati Ohio 45231

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Oklahoma

Oregon

Medford Oregon 97504-8741

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pennsylvania

Allergy & Asthma Specialists, P.C.
Blue Bell Pennsylvania 19422

A clinical research study for dust mite-induced allergies.

View More ▼

Philadelphia Pennsylvania 19104-3413

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

South Carolina

Mt. Pleasant South Carolina 29464

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Summerville South Carolina 29485

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Texas

Arlington Texas 76014

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Utah

Salt Lake City Utah 84108

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Virginia

Virginia Research Center
Midlothian Virginia 23114

SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

Virginia Research Center
Richmond Virginia 23114

SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

View More ▼

Fairfax Virginia 22030

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Washington

ASTHMA, Inc.
Seattle Washington 98115

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

ASTHMA, Inc.
Seattle Washington 98115

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

View More ▼

Everett Washington 98208

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Wisconsin

University of Wisconsin Madison
Madison Wisconsin 53792

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

University of Wisconsin – Madison
Madison Wisconsin 53792

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Argentina

Buenos Aires C1125ABE

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Buenos Aires B1842DID

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma